Trial Profile
Periprocedural rivaroxaban in Atrial Fibrillation Ablation, a multicentre registry.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Embolism and thrombosis
- Focus Adverse reactions; Therapeutic Use